Treatment of chronic delta hepatitis: A nine-year retrospective analysis

Hepatitis Monthly

Volumn 11, Issue 9, 2011, Pages 731-735

  Gulsun, Serda ^a   Tekin, Recep ^b   Bozkurt, Fatma ^b  

^a Diyarbakir Devlet Hastanesi   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Chronic delta hepatitis; Pegylated interferon; Treatment

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; PEGINTERFERON ALPHA2A; VIRUS RNA;

ADULT; ANTIBODY TITER; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS DELTA VIRUS; HISTOPATHOLOGY; HUMAN; MALE; PATIENT ASSESSMENT; RECURRENCE RISK; RETROSPECTIVE STUDY; VIROLOGY;

EID: 80053646100     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.728     Document Type: Article

References (16)

1. Rizzetto M, Verme G, Recchia S, Bonino F, Farci P, Arico S, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med. 1983; 98(4):437-41.
2. Farci P. Treatment of chronic hepatitis D: New advances, old challenges. Hepatology. 2006; 44(3):536-9.
3. Yurdaydin C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat. 2010; 1711): 749-56.
4. Cihan Y. Chronic delta hepatitis: An overview. Hepb Annual. 2008; 5(1):81-94.
5. Tekin R, Ayaz C, Celen M. Efficiency of Treatment of Long Period Pegylated interferon in Delta Hepatitis. Anatol J Clin Invest. 2010; 4(4):206-9.
6. Niro GA, Smedile A, Ippolito AM, Ciancio A, Fontana R, Olivero A, et al. Outcome of chronic delta hepatitis in Italy: a long-term cohort study. J Hepatol. 2010; 53(5):834-40.
7. Braks RE, Ganne-Carrie N, Fontaine H, Paries J, Grando-Lemaire V, Beaugrand M, et al. Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin. World J Gastroenterol. 2007; 1342): 5648-53.
8. Rizzetto M. Hepatitis Delta. Viral Hepatitis. X International Symposium on Viral Hepatitis 2010; Barcelona, Spain. 2010. p. 115-22.
9. Yurdaydin C, Bozkaya H, Karaaslan H, Onder FO, Erkan OE, Yalcin K, et al. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis. J Viral Hepat. 2007; 1411): 812-6.
10. Gunsar F, Akarca US, Ersoz G, Kobak AC, Karasu Z, Yuce G, et al. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir Ther. 2005; 10(6):721-6.
11. Heller T, Rottman Y, Hainess-Williams V, Kleiner D, Ghany M, Liang T. Long-term, high dose peginterferon alfa 2a is an effective treatment for chronic hepatitis D. Hepatology. 2009; 50:734A.
12. Farci P. Delta hepatitis: an update. J Hepatol. 2003; 39(Suppl 1):S212-9.
13. Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, et al. Efficacy of peginterferon alpha-2b in chronic hepati tis delta: relevance of quantitative RT-PCR for follow-up. Hepatology. 2006; 44(3):728-35.
14. Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology. 2006; 44(3):713-20.
15. Yurdaydin C, Bozkaya H, Onder FO, Senturk H, Karaaslan H, Akdogan M, et al. Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. J Viral Hepat. 2008; 15(4):314-21.
16. Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int. 2006; 26(7):805-10.